Six-month therapy for abdominal tuberculosis

Jullien, Sophie, Jain, Siddharth, Ryan, Hannah and Ahuja, Vineet (2016) 'Six-month therapy for abdominal tuberculosis'. Cochrane Database of Systematic Reviews, Vol 16, CD012163.

Preview

Text Jullien_et_al-2016-.pdf - Published Version Available under License Creative Commons Attribution. Download (140kB) | Preview

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the effects of six-month versus longer regimens for abdominal tuberculosis (TB), consisting of a two-month intensive phase with rifampicin, isoniazid, pyrazinamide, and ethambutol followed by a four-month or longer continuation phase including at least isoniazid and rifampicin.

Item Type:	Article
Subjects:	QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268 Antitubercular agents. Antitubercular antibiotics QW Microbiology and Immunology > Bacteria > QW 125 Actinibacteria, Actinomycetales. WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 310 Therapy
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1002/14651858.cd012163.pub2
SWORD Depositor:	JISC Pubrouter
Depositing User:	Stacy Murtagh
Date Deposited:	03 Jan 2018 13:44
Last Modified:	11 May 2018 08:51
URI:	https://archive.lstmed.ac.uk/id/eprint/8027

Statistics

View details

Actions (login required)

Edit Item